Prognostic implications of treatment delays in the surgical resection of lung cancer

Thoracic Surgery Clinics

Volumn 23, Issue 2, 2013, Pages 225-232

  Evans, William K ^a  

^a JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Diagnosis; Lung cancer; Prognosis; Wait times

Indexed keywords

CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; EARLY DIAGNOSIS; ELECTIVE SURGERY; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; LUNG CANCER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; REVIEW; THERAPY DELAY;

DELAYED DIAGNOSIS; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; PROGNOSIS; TIME FACTORS;

EID: 84875895064     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2013.01.006     Document Type: Review

References (58)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics Canadian cancer statistics 2012 2012, Canadian Cancer Society, Toronto, ISSN 0835-2976.
2. Groome P.A., Bolejack V., Crowley J.J., on behalf of the International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee and Participating Institutions, et al. The IASLC lung cancer staging project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol 2007, 2(8):694-705.
3. Brundage M., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer. A decade of progress. Chest 2002, 122:1037-1057.
4. Arai T., Kuroishi T., Saito Y., et al. Tumour doubling time and prognosis in lung cancer. Jpn J Clin Oncol 1994, 24(4):199-204.
5. Honda O., Johkoh T., Sekiguchi J., et al. Doubling time of lung cancer determined using three-dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma. Lung Cancer 2009, 66(2):211-217.
6. Radzikowska E., Roszkowowski-Sliz K., Glaz P. The impact of timeliness of care on survival in non-small cell lung cancer. Pneumonol Alergol Pol 2012, 80(5):422-429.
7. Radzikowska E., Glaz P., Roszkowski K. Lung cancer management and prognosis. Pneumonol Alergol Pol 2001, 69:600-610.
8. Fergusson R.J., Gregor A., Dodds R., et al. Management of lung cancer in South East Scotland. Thorax 1996, 51:569-574.
9. Koyi H., Hillerdal G., Branden E. Patient's and doctor's delays in the diagnosis of chest tumours. Lung Cancer 2002, 35:53-57.
10. Olsson J.K., Schultz E.M., Gould M.K. Timeliness of care in patients with lung cancer: a systematic review. Thorax 2009, 64:749-756.
11. Comber H., Korin D.P., Deady S., et al. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J 2005, 98:238-239.
12. Neal R.D., Allgar V.L., Ali N. Stage, survival and delays in lung cancer, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Br J Gen Pract 2007, 57:212-219.
13. Myrdal G., Lambe M., Hillerdal G., et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004, 59:45-49.
14. Gonzalez-Barcala F.J., Garcia-Prim J.M., Alvarez-Dobano J.M., et al. Effects of delays on survival in patients with lung cancer. Clin Transl Oncol 2011, 12:836-842.
15. Skaug K., Eide G.E., Gulsvik A. Predictors of long term survival of lung cancer patients in Norwegian community. Clin Respir J 2011, 5:50-58.
16. Salomaa E.R., Sallinen S., Hiekkanen H., et al. Delays in the diagnosis and treatment of lung cancer. Chest 2005, 128:2282-2288.
17. Porta M., Gallen M., Malats N., et al. Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health 1991, 45:225-230.
18. Siciliani L., Hurst J. Tackling excessive waiting times for elective surgery: a comparative analysis of policies in 12 OECD countries. Health Policy 2005, 72:201-215.
19. Billing J.S., Wells F.C. Delays in the diagnosis and surgical treatment of lung cancer. Thorax 1996, 51:903-906.
20. Liberman M., Liberman D., Sampalis J.S., et al. Delays to surgery in non-small-cell lung cancer. Can J Surg 2006, 49:31-36.
21. Naruke T., Tsuchiya R., Kondo H., et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM staging classification: the Japanese experience. Ann Thorac Surg 2001, 71:1759-1764.
22. Murray P.V., O'Brien M.E., Sayer R., et al. The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralized two-stop pathway. Lung Cancer 2003, 42:283-290.
23. Kesson E., Bucknall C.E., McAlpine L.G., et al. Lung cancer - management and outcome in Glasgow, 1991-92. Br J Cancer 1998, 78(10):1391-1395.
24. Watkin S.W., Hayhurst G.K., Green J.A. Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region 1974-86. Br J Cancer 1990, 61:590-596.
25. Gregor A., Thomson C.S., Brewster D.H., et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001, 56:212-217.
26. Laroche C., Wells F., Coulden R., et al. Improving surgical resection rate in lung cancer. Thorax 1998, 53:445-449.
27. Dransfeld M.T., Lock B.J., Garver R.I. Improving the lung cancer resection rate in the US Department of Veterans Affairs health system. Clin Lung Cancer 2006, 7(4):268-272.
28. United States Department of Veterans Affairs. Available at: Accessed November 4, 2005. http://www.va.gov.
29. Humphrey E., Smart C., Winchester D., et al. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg 1990, 100:837-843.
30. Fry W., Menck H., Winchester D. The national cancer database report in lung cancer. Lung Cancer 1996, 77:1947-1955.
31. Ringbaek T., Borgeskov S., Lange P., et al. Diagnostic and therapeutic process and prognosis in suspected lung cancer. Scand Cardiovasc J 1999, 33:337-343.
32. Pita-Fernandez S., Montero-Martinez C., Pertega-Diaz S., et al. Relationship between delayed diagnosis and the degree of invasion and survival in lung cancer. J Clin Epidemiol 2003, 56:820-825.
33. Loh L.C., Chan L.Y., Tan R.Y., et al. Effect of time delay on survival in patients with non small cell lung cancer - a Malaysian study. Asia Pac J Public health 2006, 18:69-71.
34. Bozcuk H., Martin C. Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer 2001, 34:243-252.
35. Aragoneses F.G., Moreno N., Leon P., et al. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 2002, 36:59-63.
36. Kashiwabara K., Koshi S., Ota K., et al. Outcome in patients with lung cancer found retrospectively to have had evidence of disease on past lung cancer mass screening roentgenograms. Lung Cancer 2002, 35:237-241.
37. Quarterman R.L., McMillan A., Ratcliffe M.B., et al. Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer. J Thorac Cardiovasc Surg 2003, 125:108-113.
38. Buccheri G., Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J 2004, 24:898-904.
39. Kanashiki M., Satoh H., Ischikawa H., et al. Time from finding abnormality on mass-screening to final diagnosis for lung cancer. Oncol Rep 2003, 10:649-652.
40. Kashiwabara K., Koshi S., Itonaga K., et al. Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor. Lung Cancer 2003, 40:67-72.
41. Annakkaya A.N., Arbal P., Balbay O., et al. Effect of symptom-to-treatment interval on prognosis in lung cancer. Tumori 2007, 93:61-67.
42. International Early Lung Cancer Action Program Investigators, Henschke C.I., Yankelevitz D.F., Libby D.M., et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355(17):1763-1771.
43. The National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
44. Dubayova T., van Dijk J.P., Nagyova I., et al. The impact of the intensity of fear on patient's delay regarding health care seeking behaviour: a systematic review. Int J Public Health 2010, 55:459-468.
45. Dracup K., Moser D. Beyond socio-demographic: factors influencing to seek treatment for symptoms of acute myocardial infarction. Heart Lung 1997, 26:253-262.
46. Lo D.S., Zeldin R.A., Skrastins R., et al. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol 2007, 2:1001-1006.
47. Gagliardi A., Grunfeld E., Evans W.K. Evaluation of diagnostic assessment units in oncology: a systematic review. J Clin Oncol 2004, 22:1126-1135.
48. Clausen J., Hsieh Y.C., Acharaya S., et al. Results of the Lynn Sage Second-Opinion Program for local therapy in patients with breast carcinoma: changes in management and determinants of where care is delivered. Cancer 2002, 94:889-894.
49. Staradub V.L., Messenger K.A., Hao N., et al. Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol 2002, 9:982-987.
50. Birkmeyer J.D., Siewers A., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346:1128-1137.
51. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003, 349:2117-2127.
52. Brouwers M, Crawford J, Elison P, et al. Organizational standards for diagnostic assessment programs. Available at: Accessed October 10, 2012. http://www.cancercare.on.ca/toolbox/qualityguidelines/other-reports/collaborative-pr-ebs/.
53. Available at: Accessed October 15, 2012. https://www.cancercare.on.ca/ocs/qpi/dispathmgmt/disease_pathway_maps/.
54. Department of Health Referral guidelines for suspected cancer 2000, Department of Health, London.
55. Department of Health The NHS cancer plan 2000, Department of Health, London.
56. British Thoracic Society BTS recommendations to respiratory physicians for organizing the care of patients with lung cancer: the Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax 1998, 53(Suppl 1):S1-S8.
57. Reifel J. Lung cancer. Quality of care for oncologic conditions and HIV: a review of the literature and quality indicators 2000, RAND Corporation, Available at:, Accessed October 10, 2012. http://www.rand.org/pubs/monograph_reports/MR1281, S. AQsch, E. Kerr, E. Hamilton (Eds.).
58. Simunovic M., Gagliardi A., McCready D., et al. A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ 2001, 165:421-425.